Literature DB >> 24375917

In vitro differentiation of mesenchymal stem cells into mesangial cells when co-cultured with injured mesangial cells.

Chee-Yin Wong1, Eng-Lai Tan, Soon-Keng Cheong.   

Abstract

Mesangial cells are one of the three major cell types of the kidney glomerulus that provide physical support for the glomerular capillary lumen of the kidney. Loss of mesangial cells due to pathologic conditions, such as glomerulonephritis and diabetic nephropathy, can impair renal function. Mesenchymal stem cells (MSC) are attractive candidates for kidney repair therapy since they can enhance recovery and protect against kidney failure. MSC can differentiate into mesangial cells in vivo. We have investigated the ability of MSC to differentiate into mesangial cells in vitro; they were co-cultured with oxidant-injured mesangial cells before being analysed by flow cytometry and for contractility. MSC co-cultured with injured mesangial cells had a mesangial cell-like morphology and contracted in response to angiotensin II. They expressed CD54(-) CD62E(+) in direct contrast to the CD54(+) CD62E(-) of pure MSC. In conclusion, MSC can differentiate into mesangial cells in vitro when co-cultured with injured mesangial cells.
© 2013 International Federation for Cell Biology.

Entities:  

Keywords:  co-culture; in vitro differentiation; kidney injury; mesangial cell; mesenchymal stem cell

Mesh:

Substances:

Year:  2014        PMID: 24375917     DOI: 10.1002/cbin.10231

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  9 in total

1.  Human mesenchymal stroma/stem cells exchange membrane proteins and alter functionality during interaction with different tumor cell lines.

Authors:  Yuanyuan Yang; Anna Otte; Ralf Hass
Journal:  Stem Cells Dev       Date:  2015-01-26       Impact factor: 3.272

Review 2.  Stem cell-based treatment of kidney diseases.

Authors:  Binbin Pan; Guoping Fan
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-11

3.  BAFF promotes proliferation of human mesangial cells through interaction with BAFF-R.

Authors:  Nuoyan Zheng; Donxian Wang; Hongyan Ming; Haiqing Zhang; Xueqing Yu
Journal:  BMC Nephrol       Date:  2015-05-15       Impact factor: 2.388

Review 4.  Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy.

Authors:  Janaina Paulini; Eliza Higuti; Rosana M C Bastos; Samirah A Gomes; Érika B Rangel
Journal:  Stem Cells Int       Date:  2016-12-13       Impact factor: 5.443

5.  Decoding the differentiation of mesenchymal stem cells into mesangial cells at the transcriptomic level.

Authors:  Chee-Yin Wong; Yao-Ming Chang; Yu-Shuen Tsai; Wailap Victor Ng; Soon-Keng Cheong; Ting-Yu Chang; I-Fang Chung; Yang-Mooi Lim
Journal:  BMC Genomics       Date:  2020-07-07       Impact factor: 3.969

6.  Development of a Novel Hanging Drop Platform for Engineering Controllable 3D Microenvironments.

Authors:  Chin-Yi Cho; Tzu-Hsiang Chiang; Li-Hung Hsieh; Wen-Yu Yang; Hsiang-Hao Hsu; Chih-Kuang Yeh; Chieh-Cheng Huang; Jen-Huang Huang
Journal:  Front Cell Dev Biol       Date:  2020-05-07

Review 7.  Concise review: current trends on applications of stem cells in diabetic nephropathy.

Authors:  Dongwei Liu; Wen Zheng; Shaokang Pan; Zhangsuo Liu
Journal:  Cell Death Dis       Date:  2020-11-21       Impact factor: 8.469

Review 8.  Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease.

Authors:  Jiali Wang; Yongda Lin; Xiutian Chen; Yiping Liu; Tianbiao Zhou
Journal:  Front Cell Dev Biol       Date:  2022-10-04

Review 9.  Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models.

Authors:  Adriana Torres Crigna; Cristina Daniele; Carolina Gamez; Sara Medina Balbuena; Diego O Pastene; Daniela Nardozi; Cinzia Brenna; Benito Yard; Norbert Gretz; Karen Bieback
Journal:  Front Med (Lausanne)       Date:  2018-06-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.